Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.18B P/E - EPS this Y -2,366.70% Ern Qtrly Grth -
Income -57.05M Forward P/E 179.35 EPS next Y 129.70% 50D Avg Chg -5.00%
Sales 547.47M PEG -0.57 EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 7.31 EPS next 5Y 96.10% 52W High Chg -36.00%
Recommedations 2.00 Quick Ratio 1.38 Shares Outstanding 58.27M 52W Low Chg 6.00%
Insider Own 8.93% ROA -2.15% Shares Float 50.15M Beta 1.00
Inst Own 93.74% ROE -13.28% Shares Shorted/Prior 4.46M/3.83M Price 55.60
Gross Margin 87.15% Profit Margin -10.42% Avg. Volume 810,170 Target Price 64.93
Oper. Margin -10.75% Earnings Date Oct 30 Volume 1,136,104 Change -1.75%
About Inari Medical, Inc.

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Inari Medical, Inc. News
12/19/24 Inari Medical price target raised to $63 from $50 at Truist
12/11/24 Inari Medical Stock Gets RS Rating Upgrade
12/04/24 Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?
12/04/24 Reasons to Retain Inari Medical Stock in Your Portfolio for Now
12/03/24 NARI Stock Likely to Gain Following Reimbursement Approval in Japan
12/03/24 Inari Medical enters China distribution partnership
12/02/24 Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
12/02/24 Inari Medical Announces Joint Venture in Greater China
11/29/24 Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?
11/18/24 Inside a $400 billion bet on the brain-computer interface revolution
11/07/24 Is Inari Medical (NARI) Trading at an Attractive Valuation?
11/06/24 Inari Medical to Participate in the Jefferies London Healthcare Conference
10/31/24 Edwards, Medtronic and Inari share trial data at TCT conference
10/30/24 Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
10/29/24 Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...
10/29/24 PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
10/29/24 Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y
04:55 PM Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
03:05 PM Inari Medical Reports Third Quarter 2024 Financial Results
10/23/24 Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hoffman William Director Director Dec 04 Option 0.43 103,492 44,502 1,070,493 12/06/23
Tu Thomas Chief Medical Office.. Chief Medical Officer Nov 16 Sell 59.87 25,451 1,523,751 320,932 11/17/23
Hykes Andrew President and CEO President and CEO Nov 16 Sell 59.87 37,448 2,242,012 434,817 11/17/23
Hoffman William Director Director Nov 15 Sell 60.75 25,000 1,518,750 967,001 11/17/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Nov 13 Sell 56.2 6,500 365,300 170,230 11/15/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Nov 13 Option 0.46 6,500 2,990 176,730 11/15/23
MILDER DONALD B Director Director Nov 07 Buy 53.07 56,100 2,977,227 3,031,714 11/08/23
Hoffman William Director Director Oct 16 Sell 56.32 25,000 1,408,000 992,001 10/18/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Sep 12 Sell 67.55 6,500 439,075 171,802 09/14/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Sep 12 Option 0.46 6,500 2,990 178,302 09/14/23
Hykes Andrew President and CEO President and CEO Aug 16 Sell 66.74 36,676 2,447,756 475,132 08/18/23
Tu Thomas Chief Medical Office.. Chief Medical Officer Aug 16 Sell 66.74 24,926 1,663,561 347,997 08/18/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Jun 12 Sell 59.63 6,500 387,595 173,054 06/13/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Jun 12 Option 0.46 6,500 2,990 179,554 06/13/23
Hoffman William Director Director May 15 Sell 70.28 106,897 7,512,721 1,120,643 05/18/23
Hykes Andrew President and CEO President and CEO May 16 Sell 70.03 36,676 2,568,420 513,608 05/18/23
Tu Thomas Chief Medical Office.. Chief Medical Officer May 16 Sell 70.03 24,927 1,745,638 373,727 05/18/23
Hoffman William Director Director Apr 17 Sell 64.72 25,000 1,618,000 1,227,540 04/19/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Apr 12 Sell 64.76 12,750 825,690 179,304 04/14/23
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Apr 12 Option 0.46 6,500 2,990 192,054 04/14/23
Hoffman William Director Director Mar 12 Sell 60.1 5,000 300,500 1,252,540 03/14/23
Hoffman William Director Director Mar 12 Option 0 961,350 1,257,540 03/14/23
Tu Thomas Chief Medical Office.. Chief Medical Officer Feb 27 Sell 56.8 10,000 568,000 107,112 03/01/23
Tu Thomas Chief Medical Office.. Chief Medical Officer Feb 27 Option 0.46 10,000 4,600 117,112 03/01/23
Hykes Andrew President and CEO President and CEO Jan 20 Sell 62.01 9,000 558,090 93,046 01/24/23
Tu Thomas Chief Medical Office.. Chief Medical Officer Dec 27 Sell 64.24 10,000 642,400 86,451 12/28/22
Tu Thomas Chief Medical Office.. Chief Medical Officer Dec 27 Option 0.46 10,000 4,600 96,451 12/28/22
Hoffman William President and CEO President and CEO Dec 15 Option 0.43 55,000 23,650 292,481 12/16/22
Hoffman William President and CEO President and CEO Dec 15 Sell 67 55,000 3,685,000 237,481 12/16/22
Tu Thomas Chief Medical Office.. Chief Medical Officer Oct 27 Sell 76.21 10,000 762,100 96,451 10/28/22
MILDER DONALD B Director Director Sep 15 Sell 80.25 7,000 561,750 3,199,614 09/16/22
Hoffman William President and CEO President and CEO Sep 07 Option 0.43 30,000 12,900 408,901 09/09/22
Hoffman William President and CEO President and CEO Sep 07 Sell 72.02 46,308 3,335,102 362,593 09/09/22
Hykes Andrew Chief Operating Offi.. Chief Operating Officer Sep 06 Sell 70.00 5,000 350,000 130,991 09/08/22
Hoffman William President and CEO President and CEO Aug 05 Option 0.43 30,000 12,900 548,899 08/09/22
Hoffman William President and CEO President and CEO Aug 05 Sell 83 30,000 2,490,000 518,899 08/09/22
Hoffman William President and CEO President and CEO Jul 18 Sell 75.29 5,275 397,155 518,899 07/20/22
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Jul 15 Sell 72.73 7,500 545,475 78,899 07/19/22
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Jul 15 Option 0.46 7,500 3,450 86,399 07/19/22
Hoffman William President and CEO President and CEO Jul 08 Sell 75.58 11,237 849,292 524,174 07/12/22
Hoffman William President and CEO President and CEO Jul 06 Option 0.43 30,000 12,900 578,899 07/08/22
Hoffman William President and CEO President and CEO Jul 06 Sell 73.15 43,488 3,181,147 535,411 07/08/22
Hykes Andrew Chief Operating Offi.. Chief Operating Officer Jul 01 Sell 70.31 5,000 351,550 140,991 07/06/22
Hykes Andrew Chief Operating Offi.. Chief Operating Officer Jun 07 Sell 70.078 5,000 350,390 146,984 06/09/22
Tu Thomas Chief Medical Office.. Chief Medical Officer May 10 Option .457 30,000 13,710 107,819 05/12/22
MILDER DONALD B Director Director Apr 18 Sell 87.83 7,000 614,810 3,654,614 04/20/22
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Apr 18 Option 0.46 7,500 3,450 87,062 04/20/22
Hill, Mitch C. Chief Financial Offi.. Chief Financial Officer Apr 18 Sell 87.8 7,500 658,500 79,562 04/20/22
Hykes Andrew Chief Operating Offi.. Chief Operating Officer Apr 01 Sell 91.22 10,000 912,200 156,984 04/05/22
ROOT JONATHAN D Director Director Jun 22 Buy 67.85 335 22,730 335 03/18/22